John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$233M |
| 2 |
Amgen
AMGN
|
+$231M |
| 3 |
Airbnb
ABNB
|
+$231M |
| 4 |
Costco
COST
|
+$210M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$263M |
| 2 |
Lowe's Companies
LOW
|
+$218M |
| 3 |
Wayfair
W
|
+$217M |
| 4 |
PepsiCo
PEP
|
+$217M |
| 5 |
Verizon
VZ
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 15.24% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 9.17% |
| 5 | Financials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVEO
2176
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.4M | ﹤0.01% |
211,723
+158,648
| +299% | +$1.09M |
|
|
RPT
2177
Rithm Property Trust
RPT
$102M
| $1.39M | ﹤0.01% |
17,893
+8,691
| +94% | +$640K |
|
2178
CALL
Shake Shack
SHAK
$2.98B
| $1.39M | ﹤0.01% |
13,000
+9,400
| +261% | +$948K |
|
|
2179
PUT
Shake Shack
SHAK
$2.98B
| $1.39M | ﹤0.01% |
13,000
+7,200
| +124% | +$726K |
|
2180
PUT
3M
MMM
$92.8B
| $1.39M | ﹤0.01% |
8,372
-10,764
| -56% | -$1.8M |
|
2181
Adicet Bio
ACET
$82.6M
| $1.38M | ﹤0.01% |
8,402
+1,999
| +31% | +$407K |
|
2182
PUT
B&G Foods
BGS
$284M
| $1.38M | ﹤0.01% |
42,100
+16,300
| +63% | +$502K |
|
2183
Amtech Systems
ASYS
$265M
| $1.38M | ﹤0.01% |
143,162
-4,057
| -3% | -$41.6K |
|
2184
Super Micro Computer
SMCI
$24.7B
| $1.38M | ﹤0.01% |
391,920
+297,920
| +317% | +$1.1M |
|
2185
WSFS Financial
WSFS
$4.02B
| $1.38M | ﹤0.01% |
+29,590
| New | +$1.51M |
|
|
HEES
2186
DELISTED
H&E Equipment Services
HEES
| $1.37M | ﹤0.01% |
41,308
-13,355
| -24% | -$489K |
|
2187
PUT
Inspire Medical Systems
INSP
$1.76B
| $1.37M | ﹤0.01% |
7,100
+4,600
| +184% | +$912K |
|
2188
Chemours
CC
$2.38B
| $1.37M | ﹤0.01% |
39,400
-31,073
| -44% | -$1.03M |
|
2189
PUT
Veeva Systems
VEEV
$39.9B
| $1.37M | ﹤0.01% |
4,400
-2,600
| -37% | -$725K |
|
2190
Curtiss-Wright
CW
$22.9B
| $1.36M | ﹤0.01% |
11,484
-4,766
| -29% | -$596K |
|
2191
CALL
Tandem Diabetes Care
TNDM
$1.49B
| $1.36M | ﹤0.01% |
14,000
+2,100
| +18% | +$187K |
|
2192
CorMedix
CRMD
$664M
| $1.36M | ﹤0.01% |
+198,700
| New | +$1.58M |
|
|
KALV
2193
DELISTED
KalVista Pharmaceuticals
KALV
| $1.36M | ﹤0.01% |
56,878
-23,795
| -29% | -$623K |
|
|
ODT
2194
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.36M | ﹤0.01% |
390,584
-258,935
| -40% | -$889K |
|
2195
Diodes
DIOD
$4.29B
| $1.36M | ﹤0.01% |
+17,051
| New | +$1.31M |
|
2196
CALL
RH
RH
$2.66B
| $1.36M | ﹤0.01% |
2,000
-8,400
| -81% | -$5.46M |
|
|
SWTX
2197
DELISTED
SpringWorks Therapeutics
SWTX
| $1.36M | ﹤0.01% |
16,464
-38,619
| -70% | -$2.93M |
|
2198
PUT
National Beverage
FIZZ
$3.1B
| $1.36M | ﹤0.01% |
28,700
+6,500
| +29% | +$315K |
|
|
GOOS
2199
PUT
Canada Goose Holdings
GOOS
$812M
| $1.36M | ﹤0.01% |
31,000
+3,000
| +11% | +$122K |
|
2200
Phathom Pharmaceuticals
PHAT
$696M
| $1.35M | ﹤0.01% |
39,984
-14,671
| -27% | -$525K |
|
Similar funds
John Overdeck's Q2 2021 Portfolio in Review
As of Q2 2021, John Overdeck held 4,837 positions worth $44.1B, up 15% from $38.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.
John Overdeck deployed $2.44B of net new capital in Q2 2021, opening 1,073 new positions and adding to 1,470 existing holdings. Its largest new stake was Amgen: 939,881 shares worth $229M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Verizon, an estimated $206M trimmed.
- John Overdeck's largest Q2 2021 buy was Amgen: 939,881 shares worth $229M.
- John Overdeck added most to Starbucks in Q2 2021, an estimated $233M increase.
- John Overdeck's biggest Q2 2021 reduction was Verizon, cutting an estimated $206M.
- John Overdeck fully exited Amazon in Q2 2021, selling an estimated $263M.
- John Overdeck's ten largest holdings make up 6.1% of its $44.1B portfolio in Q2 2021.
- John Overdeck opened 1,073 new positions and closed 875 in Q2 2021.
- John Overdeck's portfolio value rose 15% quarter-over-quarter to $44.1B.
Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.